US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

33.73

-0.8400-2.43%

Post-market: 33.730.00000.00%17:06 EDT

Volume:288.05K

Turnover:9.93M

Market Cap:949.37M

PE:-19.06

High:35.49

Open:35.35

Low:33.65

Close:34.57

Loading ...

Overview Company News Filings

Argenica Therapeutics Issues New Shares Following Option Exercise

Argenica Therapeutics Announces Cessation of Securities

INOVIQ Ltd to Host Investor Briefing on Cancer Diagnostics and Therapeutics

Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics today

Positive Outlook for Larimar Therapeutics: Promising Data on Nomlabofusp and Anticipated Catalysts Drive Buy Rating

Revive Therapeutics Updates on Nerve Agent Countermeasure Study

Entero Therapeutics Regains Nasdaq Compliance

Cargo Therapeutics price target raised to $5 from $3.70 at Jefferies

ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds

Silexion Therapeutics Stays Listed on Nasdaq After Appeal

Dermata Therapeutics receives notice of grant of Australian patent

Unicycive Therapeutics regains compliance with Nasdaq bid price requirement

Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis

Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA

Crispr Therapeutics Price Target Maintained With a $81.00/Share by Needham

Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia

Denali Therapeutics: Promising Developments and Strategic Focus Drive Buy Rating

D. Western Therapeutics Institute, Chordia Therapeutics to Develop Eye Disease Treatments

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LENZ/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":33.73,"timestamp":1752868800000,"preClose":34.57,"halted":0,"volume":288046,"hourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"delay":0,"floatShares":12538526,"shares":28146154,"eps":-1.769251,"marketStatus":"Market Closed","change":-0.84,"latestTime":"07-18 16:00:00 EDT","open":35.35,"high":35.485,"low":33.645,"amount":9926090.220002001,"amplitude":0.053225,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":34.57,"preHourTrading":{"tag":"盘前","latestPrice":35.3,"preClose":34.57,"latestTime":"09:29 EDT","volume":499,"amount":17604.058825,"timestamp":1752845399999},"postHourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"volumeRatio":0.8035328724389679,"impliedVol":1.0249,"impliedVolPercentile":0.8986},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":12538526,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.8035328724389679,"shares":28146154,"dividePrice":0,"high":35.485,"amplitude":0.053225,"preClose":34.57,"low":33.645,"week52Low":16.535,"pbRate":"4.94","week52High":38.93,"institutionHeld":0,"latestPrice":33.73,"eps":-1.769251,"divideRate":0,"volume":288046,"delay":0,"ttmEps":-1.769251,"open":35.35,"prevYearClose":28.87,"prevWeekClose":34.69,"prevMonthClose":29.31,"prevQuarterClose":29.31,"fiveDayClose":34.69,"twentyDayClose":30.03,"sixtyDayClose":25.79},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550861216","title":"Argenica Therapeutics Issues New Shares Following Option Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2550861216","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550861216?lang=en_us&edition=fundamental","pubTime":"2025-07-09 15:18","pubTimestamp":1752045499,"startTime":"0","endTime":"0","summary":"The latest update is out from Argenica Therapeutics Ltd ( ($AU:AGN) ). Argenica Therapeutics Limited has issued 10,522 fully paid ordinary shares f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-issues-new-shares-following-option-exercise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-issues-new-shares-following-option-exercise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2550686155","title":"Argenica Therapeutics Announces Cessation of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2550686155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550686155?lang=en_us&edition=fundamental","pubTime":"2025-07-09 15:17","pubTimestamp":1752045462,"startTime":"0","endTime":"0","summary":"Argenica Therapeutics Ltd ( ($AU:AGN) ) just unveiled an announcement. Argenica Therapeutics Ltd has announced the cessation of 113,478 securities,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-announces-cessation-of-securities-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-announces-cessation-of-securities-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2550550705","title":"INOVIQ Ltd to Host Investor Briefing on Cancer Diagnostics and Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2550550705","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550550705?lang=en_us&edition=fundamental","pubTime":"2025-07-09 13:42","pubTimestamp":1752039732,"startTime":"0","endTime":"0","summary":"Inoviq Ltd ( ($AU:IIQ) ) has shared an announcement. INOVIQ Ltd announced an upcoming online Investor Briefing scheduled for July 14, 2025, to disc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inoviq-ltd-to-host-investor-briefing-on-cancer-diagnostics-and-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inoviq-ltd-to-host-investor-briefing-on-cancer-diagnostics-and-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4181","BK4218","HST","BK4588","BK4539","BK4007","BK4585","LENZ"],"gpt_icon":0},{"id":"2550572225","title":"Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics today","url":"https://stock-news.laohu8.com/highlight/detail?id=2550572225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550572225?lang=en_us&edition=fundamental","pubTime":"2025-07-09 08:50","pubTimestamp":1752022208,"startTime":"0","endTime":"0","summary":"20:47 EDT Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ultimate source for rea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-crispr-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-crispr-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4588","CRSP","BK4611","LU1861559042.SGD","BK4585","LU1861558580.USD","LENZ","ARKK","BK4139","BK4544","BK4556"],"gpt_icon":0},{"id":"2550324572","title":"Positive Outlook for Larimar Therapeutics: Promising Data on Nomlabofusp and Anticipated Catalysts Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550324572","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550324572?lang=en_us&edition=fundamental","pubTime":"2025-07-09 08:25","pubTimestamp":1752020716,"startTime":"0","endTime":"0","summary":"Samantha Semenkow, an analyst from Citi, maintained the Buy rating on Larimar Therapeutics. The associated price target remains the same with $14.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-larimar-therapeutics-promising-data-on-nomlabofusp-and-anticipated-catalysts-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-larimar-therapeutics-promising-data-on-nomlabofusp-and-anticipated-catalysts-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2550575726","title":"Revive Therapeutics Updates on Nerve Agent Countermeasure Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2550575726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550575726?lang=en_us&edition=fundamental","pubTime":"2025-07-09 05:37","pubTimestamp":1752010662,"startTime":"0","endTime":"0","summary":"An update from Revive Therapeutics ( ($TSE:RVV) ) is now available. Revive Therapeutics has clarified the status of its research study on Bucillami...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/revive-therapeutics-updates-on-nerve-agent-countermeasure-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/revive-therapeutics-updates-on-nerve-agent-countermeasure-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007"],"gpt_icon":0},{"id":"2550575831","title":"Entero Therapeutics Regains Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2550575831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550575831?lang=en_us&edition=fundamental","pubTime":"2025-07-09 04:52","pubTimestamp":1752007964,"startTime":"0","endTime":"0","summary":"The latest update is out from Entero Therapeutics ( ($ENTO) ). On July 3, 2025, Entero Therapeutics, Inc. received a notification from Nasdaq confi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/entero-therapeutics-regains-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/entero-therapeutics-regains-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","LU2210150020.SGD","BK4539","MNQmain","USAW.SI","USJW.SI",".IXIC","NVIW.SI","BK4139","NQmain","BK4007","IE00B64PRP62.GBP","NDAQ","PSQ","QID","SQQQ","TSYW.SI","BK4585","TQQQ","IE00BGHQF748.EUR","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4588","LU2210149790.SGD","QLD","BK4112"],"gpt_icon":0},{"id":"2550524453","title":"Cargo Therapeutics price target raised to $5 from $3.70 at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2550524453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550524453?lang=en_us&edition=fundamental","pubTime":"2025-07-09 00:35","pubTimestamp":1751992511,"startTime":"0","endTime":"0","summary":"Jefferies raised the firm’s price target on Cargo Therapeutics (CRGX) to $5 from $3.70 and keeps a Hold rating on the shares. The firm believes Car...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cargo-therapeutics-price-target-raised-to-5-from-3-70-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cargo-therapeutics-price-target-raised-to-5-from-3-70-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2550524593","title":"ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2550524593","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550524593?lang=en_us&edition=fundamental","pubTime":"2025-07-09 00:30","pubTimestamp":1751992200,"startTime":"0","endTime":"0","summary":"WESTON, Fla., July  08, 2025  (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3112068/0/en/ZyVersa-Therapeutics-Announces-a-Warrant-Inducement-Transaction-for-2-0-Million-in-Gross-Proceeds.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2549239805","title":"Silexion Therapeutics Stays Listed on Nasdaq After Appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2549239805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549239805?lang=en_us&edition=fundamental","pubTime":"2025-07-08 21:57","pubTimestamp":1751983064,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics ( ($SLXN) ) has issued an update. On July 7, 2025, Silexion Therapeutics received a favorable decision from a Nasdaq hearings...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/silexion-therapeutics-stays-listed-on-nasdaq-after-appeal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/silexion-therapeutics-stays-listed-on-nasdaq-after-appeal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2095319765.USD","NVIW.SI","USAW.SI","QID","USJW.SI","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","BK4112","LENZ","IE00B64PRP62.GBP","BK4007","QLD","BK4139","BK4539","NQmain","BK4585","TSYW.SI","SQQQ",".IXIC","IE00BGHQF748.EUR","LU2210150020.SGD","MNQmain","TQQQ","NDAQ","IE00B3QW5Z07.USD","PSQ"],"gpt_icon":0},{"id":"2549378547","title":"Dermata Therapeutics receives notice of grant of Australian patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2549378547","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549378547?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:50","pubTimestamp":1751979059,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics (DRMA) announced the Australian Patent Office has granted its patent application for its DMT410 program for the treatment of h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dermata-therapeutics-receives-notice-of-grant-of-australian-patent-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dermata-therapeutics-receives-notice-of-grant-of-australian-patent-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","DRMA","BK4539","BK4139"],"gpt_icon":0},{"id":"2549547685","title":"Unicycive Therapeutics regains compliance with Nasdaq bid price requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549547685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549547685?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:50","pubTimestamp":1751979047,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) has regained compliance with Nasdaq continued listing standard for minimum share price. On July 7, the company receiv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-regains-compliance-with-nasdaq-bid-price-requirement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-regains-compliance-with-nasdaq-bid-price-requirement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SQQQ","LU2210149790.SGD","BK4585","TQQQ","BK4007","BK4112","NQmain","LU2095319765.USD","IE00B3QW5Z07.USD","QLD","PSQ",".IXIC","NDAQ","USAW.SI","BK4539","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","MNQmain","USJW.SI","TSYW.SI","UNCY","BK4588","BK4139","LU2210150020.SGD","NVIW.SI","QID","LENZ"],"gpt_icon":0},{"id":"2549225542","title":"Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549225542","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549225542?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:30","pubTimestamp":1751977800,"startTime":"0","endTime":"0","summary":"--Nasdaq compliance follows reverse stock split previously announced on June 17, 2025LOS ALTOS, Calif., July  08, 2025  (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc.(“Unicycive” or the “Company”) (","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3111744/0/en/Unicycive-Therapeutics-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","IE0009354923.USD","UNCY","LU2210150020.SGD","BK4539","MNQmain","USAW.SI","USJW.SI",".IXIC","BK4139","NVIW.SI","NQmain","BK4007","IE00B64PRP62.GBP","BK4183","NDAQ","PSQ","QID","SQQQ","TSYW.SI","BK4585","TQQQ","IE00BGHQF748.EUR","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4588","ODD","LU2210149790.SGD","QLD","BK4112"],"gpt_icon":1},{"id":"2549544383","title":"ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544383","media":"GlobeNewswire","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544383?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:52","pubTimestamp":1751975520,"startTime":"0","endTime":"0","summary":"ApoCII amyloidosis, resulting from abnormal organ deposition of toxic fibrillar amyloid proteins, is an ultra-rare condition that mostly affects the kidneys and manifests with protein spillage into th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3111633/0/en/ZyVersa-Therapeutics-Supports-FDA-Authorized-Emergency-Compassionate-Use-of-Cholesterol-Efflux-Mediator-VAR-200-in-a-Patient-with-ApoCII-Amyloidosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","FSGS","BK4007","BK4139"],"gpt_icon":0},{"id":"2549654194","title":"Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2549654194","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549654194?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:30","pubTimestamp":1751974200,"startTime":"0","endTime":"0","summary":"Substantial clinical need expected to facilitate rapid overall trial enrollmentHOUSTON, July  08, 2025  (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3111619/0/en/Plus-Therapeutics-Announces-Initial-Patients-Successfully-Treated-in-ReSPECT-LM-Dose-Optimization-Trial-for-REYOBIQ-in-Leptomeningeal-Metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4135","PBC","BK4139","BK4007","NCI","BK4202","CNS","BK4539"],"gpt_icon":0},{"id":"2549415455","title":"Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA","url":"https://stock-news.laohu8.com/highlight/detail?id=2549415455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549415455?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:16","pubTimestamp":1751973394,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics (LRMR) announced the publication of two peer-reviewed articles highlighting nonclinical data on the therapeutic potential, pha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/larimar-therapeutics-nomlabofusp-shows-therapeutic-potential-in-fa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/larimar-therapeutics-nomlabofusp-shows-therapeutic-potential-in-fa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4535","LENZ","LRMR","BK4539","BK4007","BK4130","FA"],"gpt_icon":0},{"id":"2549549617","title":"Crispr Therapeutics Price Target Maintained With a $81.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2549549617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549549617?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:05","pubTimestamp":1751972700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRSP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 08, 2025 07:05 ET (11:05 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CRSP"],"gpt_icon":0},{"id":"2549549950","title":"Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2549549950","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549549950?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:00","pubTimestamp":1751972400,"startTime":"0","endTime":"0","summary":"Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA submiss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3111592/0/en/Larimar-Therapeutics-Publishes-Nonclinical-Data-Supporting-the-Therapeutic-Potential-of-Nomlabofusp-in-Patients-with-Friedreich-s-Ataxia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","FA","BK4007","LENZ","BK4539","FXN","BK4130"],"gpt_icon":0},{"id":"2549546170","title":"Denali Therapeutics: Promising Developments and Strategic Focus Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2549546170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549546170?lang=en_us&edition=fundamental","pubTime":"2025-07-08 18:35","pubTimestamp":1751970927,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics, with a price target of $32.00. Thomas Shra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/denali-therapeutics-promising-developments-and-strategic-focus-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/denali-therapeutics-promising-developments-and-strategic-focus-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2549513677","title":"D. Western Therapeutics Institute, Chordia Therapeutics to Develop Eye Disease Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2549513677","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549513677?lang=en_us&edition=fundamental","pubTime":"2025-07-08 15:33","pubTimestamp":1751959985,"startTime":"0","endTime":"0","summary":"D. Western Therapeutics Institute  partnered with Chordia Therapeutics to jointly research kinase inhibitors from Chordia's oncology pipeline for potential ophthalmic use, according to a Tuesday filing on the Tokyo Stock Exchange.Chordia will provide research materials and expertise related to the compound, while DWTI will conduct pharmacological and efficacy studies using its ophthalmology-focused evaluation technologies.The compound is in preclinical discovery and has kinase inhibitory activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4539","LENZ","BK4139","WRN","BK4168"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-07-18","current":-20.381494,"percent":0.009677,"low":-20.747029,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"high":-5.069183,"avg":-11.412713,"sd":4.103005,"marketCap":973012543},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543}],"updateTime":1752949786781}}}